SCM
MEDP icon

Spyglass Capital Management’s Medpace MEDP Stock Holding History

Spyglass Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8M Sell
55,755
-13,420
-19% -$6.87M 1.9% 24
2025
Q4 		$38.9M Sell
69,175
-81,707
-54% -$46.4M 1.94% 25
2025
Q3 		$77.6M Sell
150,882
-73,589
-33% -$32.1M 4.14% 13
2025
Q2 		$70.5M Sell
224,471
-17,675
-7% -$5.31M 4.16% 10
2025
Q1 		$73.8M Sell
242,146
-20,514
-8% -$6.9M 5.07% 6
2024
Q4 		$87.3M Buy
262,660
+120,778
+85% +$41M 4.91% 7
2024
Q3 		$47.4M Buy
141,882
+32,466
+30% +$12.3M 3.11% 19
2024
Q2 		$45.1M Sell
109,416
-1,395
-1% -$552K 3.3% 17
2024
Q1 		$44.8M Sell
110,811
-40,918
-27% -$14.4M 2.98% 20
2023
Q4 		$46.5M Sell
151,729
-7,544
-5% -$2.04M 3.35% 21
2023
Q3 		$38.6M Buy
159,273
+16,636
+12% +$4.25M 3.02% 20
2023
Q2 		$34.3M Buy
142,637
+98,456
+223% +$20.5M 2.48% 23
2023
Q1 		$8.31M Buy
+44,181
New +$9.14M 0.63% 25

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Spyglass Capital Management's MEDP Position: Q1 2026 in Review

Spyglass Capital Management reduced its Medpace (MEDP) stake by 19% in Q1 2026, selling an estimated $6.87M and leaving 55,755 shares worth $26.8M. The position accounts for 1.9% of the portfolio, ranked #24.

Spyglass Capital Management first reported a position in MEDP in Q1 2023 and has held it in 13 quarters since. The position peaked at $87.3M in Q4 2024. 731 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Spyglass Capital Management held 55,755 shares of Medpace worth $26.8M as of Q1 2026.
  • Spyglass Capital Management sold 13,420 Medpace shares in Q1 2026, an estimated $6.87M.
  • Medpace made up 1.9% of Spyglass Capital Management's portfolio in Q1 2026, its #24 holding.
  • Spyglass Capital Management first reported a position in Medpace in Q1 2023 and has held it in 13 quarters since.
  • Spyglass Capital Management's Medpace position peaked at $87.3M in Q4 2024.
  • 731 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Spyglass Capital Management's 13F filing for Q1 2026, filed 15 May 2026.